Inflammasome Therapeutics’ K8 Implant Cuts Lesion Growth by more than 50% in Geographic Atrophy after Three Months in Multi-Center Trial

businesswire

Inflammasome Therapeutics’ K8 Implant Cuts Lesion Growth by more than 50% in Geographic Atrophy after Three Months in Multi-Center Trial – NEWSnet – News… as it used to be

More Press Releases

May 5, 2026

AVEO Oncology, an LG Chem company, Announces Two Poster Presentations at ASCO 2026 Annual Meeting

May 5, 2026

Ontario International Airport officials plan to welcome 2.2 million passengers over summer

May 5, 2026

Spring Aging Wellness Expo Returns to South Point Hotel and Casino

May 5, 2026

Inflammasome Therapeutics’ K8 Implant Cuts Lesion Growth by more than 50% in Geographic Atrophy after Three Months in Multi-Center Trial

AVEO Oncology, an LG Chem company, Announces Two Poster Presentations at ASCO 2026 Annual Meeting

Ontario International Airport officials plan to welcome 2.2 million passengers over summer

Spring Aging Wellness Expo Returns to South Point Hotel and Casino

Skully Brandon Hits 3 Million Followers, Celebrates Milestone in Scottsdale